Skip to content
Trial Eligibility
Menu

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

NCT06944522

This study is recruiting at 34 US sites in 23 states, according to its ClinicalTrials.gov record last updated .

Summary

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Parkinsons Disease (PD)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
45 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
BlueRock Therapeutics
Last updated on ClinicalTrials.gov
August 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 2

  • Mayo Clinic Scottsdale - Neurology · Scottsdale, AZ
  • Banner Sun Health Research Institute · Sun City, AZ

Arkansas · 1

  • University of Arkansas for Medical Sciences · Little Rock, AR

California · 3

  • UCLA NeuroTranslational Research Center · Los Angeles, CA
  • UCI Medical Center - Neurology · Orange, CA
  • Stanford Neuroscience Health Center · Palo Alto, CA

Colorado · 1

  • University of Colorado Hospital - Neurology Clinic · Aurora, CO

District of Columbia · 1

  • MedStar Georgetown University Hospital · Washington D.C., DC

Florida · 3

  • Mayo Clinic Jacksonville - Neurology · Jacksonville, FL
  • University of Miami Health System - Neurology · Miami, FL
  • USF Parkinson's Disease and Movement Disorders Center · Tampa, FL

Illinois · 2

  • Parkinson's Disease and Movement Disorders Center at Northwestern Memorial Hospital · Chicago, IL
  • Rush University Medical Center - Neurology · Chicago, IL

Kansas · 1

  • University of Kansas Medical Center · Kansas City, KS

Kentucky · 1

  • University of Louisville Hospital · Louisville, KY

Maryland · 1

  • Johns Hopkins Hospital - Neurology · Baltimore, MD

Massachusetts · 2

  • Beth Israel Deaconess Medical Center · Boston, MA
  • Tufts Medical Center - Neurology · Boston, MA

Michigan · 3

  • Michigan Clinical Research Unit - Neurology · Ann Arbor, MI
  • University of Michigan Clinical Research Unit - Neurology · Ann Arbor, MI
  • Quest Research Institute · Farmington Hills, MI

New York · 3

  • UBMD Neurology · Buffalo, NY
  • Mount Sinai West - Neurology · New York, NY
  • New York Presbyterian/Weill Cornell Medical Center · New York, NY

North Carolina · 1

  • Duke Neurological Disorders Clinic · Durham, NC

Ohio · 1

  • University of Toledo Medical Center · Toledo, OH

Oregon · 1

  • OHSU Neurology Clinic, South Waterfront · Portland, OR

Rhode Island · 1

  • Rhode Island Hospital - Neurology · Providence, RI

South Carolina · 1

  • Medical University of South Carolina, Movement Disorders Dept. · Charleston, SC

Tennessee · 1

  • Vanderbilt University Medical Center · Nashville, TN

Texas · 1

  • UTHealth Houston Neurosciences - Texas Medical Center · Houston, TX

Vermont · 1

  • University of Vermont Medical Center · Burlington, VT

Virginia · 1

  • Virginia Commonwealth University · Richmond, VA

Washington · 1

  • EvergreenHealth - Research Department · Kirkland, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.